Bull Market Summer: 6 Reasons Wall Street's Rally Continues
ZACKS· 2025-07-01 22:01
With the first half of the year in the books, bulls have regained control of Wall Street. Below are six reasons that bulls will remain in control into the summer:Stocks are Entering an Election Cycle Seasonality Sweet SpotStock market seasonality is the practical study of how specific times of year often lead to repeatable patterns that traders and investors can use to gain an edge in the stock market. Seasonality was popularized Yale Hirsch, who published groundbreaking research on seasonality and cycles a ...
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
ZACKS· 2025-07-01 22:01
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this vaccine maker have returned -10.9%, compared to the Zacks S&P 500 composite's +5.2% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax falls in, has gained 0.9%. The key question now is: What could be the stock's future di ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
GlobeNewswire News Room· 2025-07-01 22:00
诉讼事件 - 针对Hims & Hers Health公司的集体诉讼已提交,指控其涉及证券欺诈或其他非法商业行为[1][2] - 诉讼涉及公司及其部分高管或董事[2] - 投资者需在2025年8月25日前申请成为首席原告[2] 合作伙伴关系变动 - 2025年4月29日公司宣布与诺和诺德建立长期合作关系,立即开始在平台销售Wegovy®捆绑产品[4] - 2025年6月23日诺和诺德终止合作,指控公司欺骗性推广和销售Wegovy®仿制品危害患者安全[4] - 诺和诺德声明指出公司违反法律大规模销售未经批准的复合药物[4] 仿制品问题 - 公司销售的仿制品活性成分来自中国供应商,未经FDA批准可能含有不安全成分[4] - 诺和诺德调查发现这些仿制品通过远程医疗实体和复合药房销售[4] 市场反应 - 合作终止消息导致公司股价单日下跌22.24美元(34.63%),收于41.98美元[4] 律所背景 - Pomerantz律师事务所在证券集体诉讼领域具有领先地位[5] - 该律所曾为证券欺诈受害者赢得数百万美元赔偿[5]
ROYAL CARIBBEAN'S FIRST ROYAL BEACH CLUB NOW AVAILABLE TO BOOK
Prnewswire· 2025-07-01 22:00
Royal Beach Club Paradise Island will deliver an all-inclusive beach day in The Bahamas in December 2025 MIAMI, July 1, 2025 /PRNewswire/ -- Vacationers can officially add the ultimate beach day to their bucket lists as Royal Caribbean has opened bookings for the first-of-its-kind beach club experience in The Bahamas. Combining the vibrant culture and beauty of The Bahamas with signature Royal Caribbean touches, Royal Beach Club Paradise Island* will redefine the ultimate beach day across all-inclusive expe ...
Booking Holdings to Webcast Second Quarter 2025 Financial Results on July 29
Prnewswire· 2025-07-01 22:00
About Booking Holdings Booking Holdings (NASDAQ: BKNG) is the world's leading provider of online travel and related services, provided to consumers and local partners in more than 220 countries and territories through five primary consumer-facing brands: Booking.com, Priceline, Agoda, KAYAK and OpenTable. The mission of Booking Holdings is to make it easier for everyone to experience the world. For more information, visit BookingHoldings.com and follow us on X @BookingHoldings. SOURCE Booking Holdings NORWA ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
GlobeNewswire News Room· 2025-07-01 22:00
[Click here for information about joining the class action] On May 8, 2025, after the market closed, Iovance released its first quarter 2025 financial results, revealing a quarterly total product revenue of $49.3 million, a significant decline from the prior quarter's $73.7 million. The Company also announced its full fiscal year 2025 total product revenue guidance had been slashed from $450 million - $475 million to $250 million - $300 million, a reduction of over 40% at the midpoint. Iovance revealed it w ...
C3.Ai's Swing Trade Potential Emerges - Profit/ SBC Risks Remain
Seeking Alpha· 2025-07-01 22:00
The analysis is provided exclusively for informational purposes and should not be considered professional investment advice. Before investing, please conduct personal in-depth research and utmost due diligence, as there are many risks associated with the trade, including capital loss. I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any qu ...
Apple: Beaten Down, But Ready To Bounce Back
Seeking Alpha· 2025-07-01 21:54
苹果公司表现 - 苹果公司作为Magnificent 7成员之一 近期表现逊色于其他同行 [1] - 尽管面临关税等外部因素影响 公司仍受到持续关注 [1] 分析师背景 - 分析师Rick拥有20年股票和期权交易经验 其作品被多家权威媒体引用 [1] - 2018年出版《The Financially Independent Millennial》分享35岁实现财务自由的经验 [1] - 除金融领域外 分析师还专注于游轮旅行和科技等领域的写作 [1]
DAVE INC (DAVE) Is a Great Choice for 'Trend' Investors, Here's Why
ZACKS· 2025-07-01 21:50
趋势投资策略 - 短期投资或交易成功的关键在于跟随趋势 但趋势的可持续性难以确保 可能导致投资者短期资本损失 [1] - 盈利交易需确认基本面稳健 盈利预测上调等因素 以维持股票动能 [1] - "近期价格强势"筛选工具有助于识别处于上升趋势且基本面强劲的股票 这些股票通常交易于52周高低区间的上部 显示看涨信号 [2] Dave Inc (DAVE)投资亮点 - 过去12周股价上涨252_2% 反映投资者对其潜在上涨空间的持续看好 [3] - 过去4周股价上涨28_4% 显示当前趋势仍在延续 [4] - 当前交易于52周高低区间的103_8% 暗示可能即将突破 [4] - 获Zacks Rank 1(强力买入)评级 位列4000多只股票的前5% 基于盈利预测修正和EPS意外的趋势 [5] 评级系统与基本面 - Zacks Rank评级系统自1988年以来 1评级股票年均回报率达+25% [6] - 平均经纪商建议评级为1(强力买入) 显示经纪商对该股短期价格表现高度乐观 [6] 其他投资工具 - 除DAVE外 还有多只股票通过"近期价格强势"筛选 [7] - Zacks提供超过45种专业筛选工具 可根据个人投资风格选择以跑赢市场 [7] - Zacks Research Wizard可回测策略有效性 并提供成功选股策略 [8]
Here's Why Momentum in Verona Pharma (VRNA) Should Keep going
ZACKS· 2025-07-01 21:50
趋势投资策略 - 短期投资或交易中趋势跟踪是最盈利的策略但趋势可持续性难以确保[1] - 趋势反转可能导致短期资本损失需通过基本面稳健、盈利预期上调等因素确认趋势延续性[2] - "近期价格动能"筛选工具可识别处于上升趋势且交易于52周高-低区间上部的股票[3] Verona Pharma股票分析 - 过去12周股价累计上涨74.2%反映市场对其潜在上涨空间的持续认可[4] - 近4周维持12.5%涨幅显示趋势未改当前股价位于52周高-低区间的94.8%接近突破点[5] - 获Zacks Rank 1(强力买入)评级位列4000多只股票前5%盈利预测修正与EPS意外为核心评级依据[6] 评级系统与基本面 - Zacks Rank 1股票自1988年以来年均回报率达25%评级系统基于四项盈利预估相关因素[7] - 券商平均推荐评级为1(强力买入)显示机构对其短期价格表现高度乐观[7] 筛选工具与策略 - 除VRNA外另有其他股票通过"近期价格动能"筛选可纳入投资考量[8] - Zacks提供超过45种定制筛选工具帮助投资者根据个人风格跑赢市场[8]